Top Markets
Coin of the day
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVXA
Classement en actions #38483
Headquartered in Dublin, Ireland, and established in 1985, Ovoca Bio plc... Headquartered in Dublin, Ireland, and established in 1985, Ovoca Bio plc operates as a clinical-stage biopharmaceutical firm dedicated to discovering and bringing to market innovative therapies for various female sexual dysfunctions. Its primary drug candidate, BP-101, is being developed as a medical treatment for premenopausal women diagnosed with hypoactive sexual desire disorder. This compound is presently in Phase II clinical investigation in Australia and New Zealand, and has progressed to Phase III clinical trials within Russia. Beyond its core pharmaceutical work, the company also participates in mineral exploration and offers supplementary support services. The organization, originally incorporated as Ovoca Gold plc, rebranded to Ovoca Bio plc in July 2018.
Prix de l'action
$0.01142111
Dernière synchronisation: 2025-03-21
Capitalisation boursière
$930.66K
Changement (1 jour)
0.18%
Changement (1 an)
-69.73%
Pays
IE
Échange Ovoca Bio plc (OVXA)

Catégorie

Bénéfices pour Ovoca Bio plc (OVXA)
Bénéfices en Jun 2024 TTM : $-5.54M
Selon les derniers rapports financiers de Ovoca Bio plc, les bénéfices actuels de l'entreprise sont de $-5.54M. En 2023, l'entreprise a réalisé un bénéfice de $-5.64M, une augmentation par rapport à celui de 2022 qui était de $-6.02M. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Ovoca Bio plc de 2001 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
2026 (TTM) $-5.54M 177,402.36%
2024 $-3.12K -99.94%
2023 $-5.64M -6.27%
2022 $-6.02M 0.89%
2021 $-5.97M 111.35%
2020 $-2.82M 32.29%
2019 $-2.13M -6.96%
2018 $-2.29M 401.73%
2017 $-457.16K -54.69%
2016 $-1.01M -58.18%
2015 $-2.41M -69.99%
2014 $-8.04M -60.54%
2013 $-20.37M 592.33%
2012 $-2.94M -153.33%
2011 $5.52M 340.98%
2010 $1.25M -87.44%
2009 $9.96M -683.08%
2008 $-1.71M 36.71%
2007 $-1.25M -81.83%
2006 $-6.88M 549.04%
2005 $-1.06M 285.00%
2004 $-275.29K 10.93%
2003 $-248.17K 96.02%
2002 $-126.60K -32.76%
2001 $-188.29K 0.00%
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
$5.27B -95,296.05%
US
$1.95B -35,303.36%
NL
$-3.09B 55,611.05%
US
$-4.02B 72,380.25%
AU
- -
CH